A hbv cccDNA digital PCR quantitative detection kit and its application
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- SHANGHAI CHROMYSKY MEDICAL RES
- Publication Date
- 2016-08-24
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of virus in vitro nucleic acid detection, and in particular relates to a HBV cccDNA digital PCR quantitative detection kit and an application thereof. Background technique
[0002] Chronic Hepatitis B (CHB) is a liver inflammatory disease caused by chronic infection of Hepatitis B Virus (HBV) in human liver cells, and its continuous progression can lead to liver cirrhosis and liver failure and liver cancer. It is estimated that there are currently about 350 million HBV carriers in the world, and about 1 million people die each year from liver failure, cirrhosis or liver cancer caused by HBV infection. In 2012, the "Guidelines for the Prevention and Treatment of Chronic Hepatitis B" jointly formulated by the Liver Disease Branch of the Chinese Medical Association and the Infectious Disease Branch of the Chinese Medical Association pointed out that there are currently about 93 million chronic HBV infections i...